Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Myelogenous Leukemia, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07552649
What this trial is testing

Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia

Who this might be right for
AML (Acute Myeloid Leukemia)
Antonio Pierini 28
Post-approval studies (Phase 4)Study completedNCT01735955
What this trial is testing

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Who this might be right for
Chronic Myelogenous Leukemia (CML)Metastatic Gastrointestinal Stromal Tumors (GIST)Acute Lymphoblastic Leukemia (ALL)+1 more
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Study completedNCT02328755
What this trial is testing

Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Michigan Rogel Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT07523555
What this trial is testing

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLLRelapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia+4 more
Beijing Biotech 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098313
What this trial is testing

HCT With PTCy in Higher-risk MDS

Who this might be right for
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
Asan Medical Center 113
Not applicableNot Yet RecruitingNCT07516353
What this trial is testing

My.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

Who this might be right for
SarcomaOsteosarcomaEwing Sarcoma+6 more
Dana-Farber Cancer Institute 143
Large-scale testing (Phase 3)Study completedNCT00428558
What this trial is testing

Timed-Sequential Induction in CBF-AML

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 200
Early research (Phase 1)Ended earlyNCT01849276
What this trial is testing

Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+14 more
Northwestern University 2
Testing effectiveness (Phase 2)Study completedNCT02666950
What this trial is testing

WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome With Isolated Del(5q)Myelodysplastic/Myeloproliferative Neoplasm+3 more
Mayo Clinic 3
Testing effectiveness (Phase 2)Ended earlyNCT00053014
What this trial is testing

S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 5
Early research (Phase 1)Study completedNCT02326584
What this trial is testing

A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myelogenous Leukemia
Seagen Inc. 116
Testing effectiveness (Phase 2)Study completedNCT00002547
What this trial is testing

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Barbara Ann Karmanos Cancer Institute 280
Large-scale testing (Phase 3)Study completedNCT01951885
What this trial is testing

Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+7 more
Case Comprehensive Cancer Center 101
Testing effectiveness (Phase 2)Study completedNCT05906914
What this trial is testing

Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, Adult
First Affiliated Hospital of Zhejiang University 65
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT02550535
What this trial is testing

A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients

Who this might be right for
Myelodysplastic Syndromes (MDS)Acute Myeloid Leukaemia (AML)
Cell Medica Ltd 3
Not applicableUnknownNCT03600558
What this trial is testing

Efficacy of FLAG Regimen for the Treatment of Patients With AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute
Tianjin Medical University General Hospital 60
Not applicableStudy completedNCT03881826
What this trial is testing

Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaCachexia
Université Catholique de Louvain 60
Large-scale testing (Phase 3)UnknownNCT05175508
What this trial is testing

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Who this might be right for
AMLMDSOld Age; Debility+1 more
The First Affiliated Hospital of Soochow University 180
Next Page
35